PlainRecalls
FDA Drug Moderate Class II Terminated

fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2

Reported: October 11, 2023 Initiated: September 21, 2023 #D-0020-2024

Product Description

fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2

Reason for Recall

Lack of assurance of sterility:

Details

Units Affected
174, 5 mL syringes.
Distribution
Nationwide in the USA
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2. Recalled by Central Admixture Pharmacy Services Inc. Units affected: 174, 5 mL syringes..
Why was this product recalled?
Lack of assurance of sterility:
Which agency issued this recall?
This recall was issued by the FDA Drug on October 11, 2023. Severity: Moderate. Recall number: D-0020-2024.